These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38083824)

  • 1. Correction to "A new computational approach, based on images trajectories, to identify the subjacent heterogeneity of sperm to the effects of ketanserin".
    Cytometry A; 2024 Feb; 105(2):157. PubMed ID: 38083824
    [No Abstract]   [Full Text] [Related]  

  • 2. A new computational approach, based on images trajectories, to identify the subjacent heterogeneity of sperm to the effects of ketanserin.
    Rodríguez-Martínez EA; Rivas CU; Ayala ME; Blanco-Rodríguez R; Juarez N; Hernandez-Vargas EA; Aragón A
    Cytometry A; 2023 Aug; 103(8):655-663. PubMed ID: 36974731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian-Estimated Hierarchical HMMs Enable Robust Analysis of Single-Molecule Kinetic Heterogeneity.
    Hon J; Gonzalez RL
    Biophys J; 2019 May; 116(10):1790-1802. PubMed ID: 31010664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of erythropoietin on platelet serotonin storage and platelet aggregation in hemodialysis patients with reference to ketanserin treatment.
    Borawski J; Rydzewski A; Pawlak K; Azzadin A; Buczko W; Mysliwiec M
    Thromb Res; 1998 May; 90(4):171-80. PubMed ID: 9692616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketanserin and capillary flow in Raynaud's phenomenon.
    Tooke JE; Williams SA; Rawlinson DW; Black C
    Int J Microcirc Clin Exp; 1990 Aug; 9(3):249-55. PubMed ID: 2394546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ketanserin on cerebral blood flow autoregulation in healthy volunteers.
    Schmidt JF; Olsen KS; Waldemar G; Jørgensen BC; Paulson OB
    Acta Neurochir (Wien); 1991; 111(3-4):138-42. PubMed ID: 1950688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic assessment of ketanserin in the horse.
    Aljuffali IA; Brainard BM; Moore JN; Kwon S; Allen D; Robertson TP; Arnold RD
    J Vet Pharmacol Ther; 2012 Oct; 35(5):472-7. PubMed ID: 22091605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational imaging of sperm locomotion.
    Daloglu MU; Ozcan A
    Biol Reprod; 2017 Aug; 97(2):182-188. PubMed ID: 29044431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motion artifact reduction on parametric PET images of neuroreceptor binding.
    Herzog H; Tellmann L; Fulton R; Stangier I; Rota Kops E; Bente K; Boy C; Hurlemann R; Pietrzyk U
    J Nucl Med; 2005 Jun; 46(6):1059-65. PubMed ID: 15937320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rationale for ketanserin therapy in hypertension.
    Hansson L; Hedner T
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S39-44. PubMed ID: 2446068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ketanserin on microcirculatory alterations in septic shock: An open-label pilot study.
    Vellinga NA; Veenstra G; Scorcella C; Koopmans M; van Roon EN; Ince C; Boerma EC
    J Crit Care; 2015 Dec; 30(6):1156-62. PubMed ID: 26264259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic approach to equilibrium between ketanserin and ketanserin-ol.
    Van Peer A; Woestenborghs R; Embrechts L; Heykants J
    Eur J Clin Pharmacol; 1986; 31(3):339-42. PubMed ID: 3792431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]ketanserin labels serotonin 5-HT2 and alpha 1-adrenergic receptors in human brain cortex.
    Hoyer D; Vos P; Closse A; Palacios JM; Engel G; Davies H
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S48-50. PubMed ID: 2446070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketanserin: a new perspective in posttransplant erythrocytosis?
    Borawski J; Mazerska M; Rydzewski A; Pawlak K; Rowinski M; Mysliwiec M
    Clin Transplant; 1996 Feb; 10(1 Pt 1):63-6. PubMed ID: 8652901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketanserin blocks alpha 1-adrenoceptors of porcine vascular smooth muscle cells.
    Nishimura J; Kanaide H; Shogakiuchi Y; Nakamura M
    Eur J Pharmacol; 1987 Jan; 133(2):235-8. PubMed ID: 2880740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketanserin and the cardiovascular response to intubation: a preliminary report.
    Murray WB; Daniel CH
    Eur J Anaesthesiol; 1987 Nov; 4(6):401-9. PubMed ID: 3328682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketanserin in essential hypertension: effects during rest and exercise.
    Persson B; Hedner T; Berglund G
    Eur J Clin Pharmacol; 1983; 25(3):307-12. PubMed ID: 6628517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ketanserin tartrate on serum lipids in patients with essential hypertension.
    Nakamura H; Hirata F; Yasugi T; Mizuno M; Saito E; Ishikawa T; Tada N; Nakaya N; Homma Y; Takeuchi I
    Drugs; 1988; 36 Suppl 1():25-34. PubMed ID: 3071460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.
    Levin ED; Slade S; Johnson M; Petro A; Horton K; Williams P; Rezvani AH; Rose JE
    Eur J Pharmacol; 2008 Dec; 600(1-3):93-7. PubMed ID: 18950618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocardium modulates myocardial inotropic response to 5-hydroxytryptamine.
    Shah AM; Andries LJ; Meulemans AL; Brutsaert DL
    Am J Physiol; 1989 Dec; 257(6 Pt 2):H1790-7. PubMed ID: 2603966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.